Allscripts completes public offering of 27,000,000 shares at $17.05 per share

Allscripts-Misys Healthcare Solutions, Inc. (Nasdaq: MDRX), the leading provider of clinical software, information and connectivity solutions for physicians, today announced that certain wholly-owned subsidiaries of Misys plc, Allscripts' majority stockholder, have completed their previously announced underwritten public offering of 27,000,000 shares of Allscripts common stock at a public offering price of $17.05 per share.  The underwriters in the offering have notified Allscripts and the selling stockholders that they have exercised in full their option to purchase 4,050,000 additional shares from the selling stockholders to cover over-allotments.

Allscripts will not receive any proceeds from the offering.

Credit Suisse, Barclays Capital, J.P. Morgan and UBS Investment Bank are acting as joint book-running managers of the offering.

In addition, Allscripts also announced today the funding and closing of the repurchase of approximately 24.4 million shares of its common stock from certain wholly-owned subsidiaries of Misys plc for an aggregate purchase price of $577.4 million, which included a payment of a previously disclosed premium of $117.4 million in connection with the sale by Misys of its controlling interest.

Allscripts financed the share repurchase through a fully syndicated credit facility consisting of a $470 million five-year term loan facility and a $250 million five-year revolving credit facility.